WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and specificity endpoints, according to results from the PREEMPT CRC study. Using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback